
    
      ENROLLMENT Patients will be recruited from all COVID-19 treating hospitals of Nepal which are
      participating in this clinical study. All hospitalized patients with moderate to severe
      COVID-19 infection will be screened for Remdesivir Treatment and those with severe to life
      threatening COVID-19 infection will be screened for Convalescent plasma therapy.

      Donors Convalescent plasma donors will be recruited from the record of the hospitals from
      where they were discharged. The COVID hospitals will be asked to collect names of recovered
      patients who have voluntarily shown interest to donate plasma. When possible donated plasma
      will be stored in respective hospitals or blood bank.
    
  